24324 Federal Register / Vol. 87, No. 79 / Monday, April 25, 2022 / Notices 

Dated:April 20, 2022 

Lanette A. Palmquist, 

Project Clearance Liaison, National Institute 

on Drug Abuse, National Institutes of Health. 

[FR Doc. 2022–08779 Filed 4–22–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Advancing 

Translational Sciences; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Center for 

Advancing Translational Sciences 

Advisory Council. 

This meeting is being held virtually 

only; there is no in-person option. The 

open sessions will be videocast and may 

be accessed by the public from the NIH 

Videocasting and Podcasting website 

(http://videocast.nih.gov). Individuals 

who need special assistance, such as 

sign language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Advancing Translational Sciences Advisory 

Council. 

Date: May 19–20, 2022. 

Closed: May 19, 2022, 11:00 a.m. to 12:30 

p.m. 

Agenda: To review, evaluate, and discuss 

internal operations. To review and evaluate 

grant applications. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, One Democracy Plaza, Room 987/ 

989, 6701 Democracy Boulevard, Bethesda, 

MD 20892 (Virtual Meeting). 

Open: May 19, 2022, 1:00 p.m. to 5:00 p.m. 

Agenda: Report from the Institute Director, 

Invited Speaker Presentation, and DPI 

Program Update. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, One Democracy Plaza, Room 987/ 

989, 6701 Democracy Boulevard, Bethesda, 

MD 20892 (Virtual Meeting). 

Open: May 20, 2022, 1:00 p.m. to 5:00 p.m. 

Agenda: OSI Program Update; view and 

discuss Clearance of Concepts. 

Place: National Center for Advancing 

Translational Sciences, National Institutes of 

Health, One Democracy Plaza, Room 987/ 

989, 6701 Democracy Boulevard, Bethesda, 

MD 20892 (Virtual Meeting). 

Contact Person: Anna L. Ramsey-Ewing, 

Ph.D., Executive Secretary, National Center 

for Advancing Translational Sciences, 

National Institutes of Health One Democracy 

Plaza, Room 1072, 6701 Democracy 

Boulevard, Bethesda, MD 20892, 301–435– 

0809, anna.ramseyewing@nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice no later than 15 days after the 

meeting at NCATSCouncilInput@

mail.nih.gov. The statement should include 

the name, address, telephone number and 

when applicable, the business or professional 

affiliation of the interested person. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.859, Pharmacology, 

Physiology, and Biological Chemistry 

Research; 93.350, B—Cooperative 

Agreements; 93.859, Biomedical Research 

and Research Training, National Institutes of 

Health, HHS) 

Dated: April 20, 2022. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–08715 Filed 4–22–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Integrative Health; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Integrative Health 

Special Emphasis Panel; HEAL Initiative: 

Developing Quantitative Imaging and Other 

Relevant Biomarkers of Myofascial Tissues 

for Clinical Pain Management. 

Date: May 19–20, 2022. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Complementary 

and Integrative Democracy II, 6707 

Democracy Blvd., Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Shiyong Huang, Ph.D., 

Scientific Review Officer, Office of Scientific 

Review, Division of Extramural Activities, 

NCCIH/NIH, 6707 Democracy Boulevard, 

Suite 401, Bethesda, MD 20817, 

shiyong.huang@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 

in Complementary and Alternative Medicine, 

National Institutes of Health, HHS) 

Dated: April 20, 2022. 

Victoria E. Townsend, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2022–08721 Filed 4–22–22; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel; 3D Aging and 

Alzheimer Brain Program. 

Date: May 31, 2022. 

Time: 11:00 a.m. to 4:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Bethesda, MD 20892, (Virtual Meeting). 

Contact Person: Birgit Neuhuber, Ph.D., 

Scientific Review Officer, Scientific Review 

Branch, Division of Extramural Activities, 

Ninds, NIH NSC, 6001 Executive Blvd., Suite 

3208, MSC 9529, Bethesda, MD 20892, 301– 

496–3562, neuhuber@ninds.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.866, Aging Research, 

National Institutes of Health, HHS) 


khammond on DSKJM1Z7X2PROD with NOTICES